Navigation Links
iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
Date:3/9/2009

iEnterprises, the global desktop and wireless customer relationship management (CRM) experts, today launched iComply, a Lotus Domino email archiving and compliance software solution. iComply helps companies more efficiently capture and store Lotus Notes email for improved compliance with government regulations, corporate policy and electronic discovery (e-discovery). The software is offered with a Lotus Notes interface or a Web- based interface, depending on users' preferences.

London, United Kingdom (PRWEB) March 9, 2009 -- iEnterprises (http://www.ienterprises.eu) today launched iComply, a Lotus Domino email archiving and compliance software solution. iComply helps companies more efficiently capture and store Lotus Notes email for improved compliance with government regulations, corporate policy and electronic discovery (e-discovery). The software is offered with a Lotus Notes interface or a Web- based interface, depending on users' preferences.

"We heavily rely on email for doing business, but without a systematic email archiving process and safeguard to meet the growing number of government regulations, companies are vulnerable to legal and financial risk," said Mark Creasey, managing director of iEnterprises Europe. "iComply helps companies with Lotus Notes take control of their email archiving and deletions in a secure, centralised and hassle free way. They can then focus on growing their core business."

Highly scalable and easy to install, iComply automatically captures and stores each email sent through the Domino mail system in a secure, feature-rich repository. Users can easily
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AdvanceMarketWoRx' Ellen Hoenig Carlson Launches Marketing and Healthcare Blog
2. Glissandra Skincare Inc. Launches Website Showcasing New and Novel Anti-Aging Skincare Products
3. Dr. Praegers Sensible Foods Launches Four New Frozen Food Products
4. Phoenix Health Systems Launches Total Security Program for the Healthcare Industry
5. Samantha Harris Launches A Toast for Everyday Health
6. Nearing Centennial, Occupational Therapy Profession Launches New Brand
7. Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases
8. Bumrungrad Launches 2009 Great Chefs Program - Top local Chefs Design Menus Based on 'Amazing Thailand'
9. Anthem Blue Cross and Blue Shield in Connecticut Launches Innovative New Program for Cities and Towns
10. Nestle Launches State-of-the-Art Factory and Beverage Distribution Center in Anderson, Indiana
11. MedicinePhone Launches TouchOut Cancer on Apple App Store

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, HARRISBURG,Pa.,Nov.24/PRNewswire-USNewswire/...Pennsylvaniansat-riskfortheH1N1fluwerevaccinateddu...mentofHealthandlocalhealthdepartments. ,, "With...esandprojectionsregardingtheavailabilityofH1N1vacc...ndell."Overall,wearepleasedwiththeH1N1vaccinedistr...
(Date:11/24/2009)...,, SANBERNARDINO,Calif.,Nov.24/PRNewswire/--Nex...cationseminarsaimedathelpingHispanic-Americansenio...r,seniorsareencouragedtotakeafreeZumba®Goldcl...msofmerengue,salsa,cumbia,rumba,andtango. ,, Un...ticipantsfeelcomfortableandengagedwhenlearningabou...
(Date:11/24/2009)...,, BIRMINGHAM,Ala.,Nov.24/PRNewswire-FirstCall/...itwillparticipateintheBankofAmericaMerrillLynch200...althSouthSeniorVicePresidentandTreasurerEdFaywillb...sentationwillbewebcastliveandwillbeavailableat htt...lelink. ,, AboutHealthSouth ,, HealthSouth...
(Date:11/24/2009)...udy finds that quitting improves heart prospects, .... 24 (HealthDay News) -- A new study offers yet mo...eath from heart disease and cancer. , Researche...female smokers, formers smokers and nonsmokers for...re 4.16 times more likely to die of cancer, 2.26 t...
(Date:11/24/2009)...November 18, 2009 - Oakland, Calif. A study condu...and scientists identifies a new class of therapeut...and possibly treat colon cancer, the third most de...al lipid molecules found in soy that research show... study, led by Julie Saba, MD, PhD, senior scienti...
Breaking Medicine News(10 mins):Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer 2
...RIVERSIDE, Calif. UC Riversides Douglas Ethell ,... studies how brain cells die in disorders such as ...20,833, five-year grant by the California Institut...esearch on human embryonic stem cells for treating...
...ION VIEJO, Calif., Dec. 13 The Ensign,Group, Inc....n(TM) group of,skilled nursing, rehabilitative car...d today that it completed the purchase of two skil...go: http://www.newscom.com/cgi-bin/prnh/20071213/...
...AGO, Dec. 13 Advanced Life Sciences,Holdings, Inc...gaged in the,discovery, development and commercial... infection, cancer and inflammation, today announc...illion shares of common stock to a group of new an...
...SBAD, Calif., Dec. 13 Isis,Pharmaceuticals, Inc. ...d and,Drug Administration (FDA) has granted orphan...n inherited form of amyotrophic lateral sclerosis ...ad to death. ISIS 333611, a second-generation anti...
...-term treatment after drug-eluting stents is key, ...remely important after implanting a drug-eluting s...to updated joint Guidelines for Percutaneous,Coron... guidelines also note that the artery-opening proc...
...CA, N.Y., Dec. 13 Capsulated Systems, Inc. at its...veloped a new proprietary,micro-particle system th...asting at least five days in vivo according to its...r a long acting,local anesthetic without the commo...
Other Medicine News:Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 2Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 3Health News:The Ensign Group, Inc. Acquires Assets of Three Previously Leased Facilities 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 3Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 2Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 3Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 2Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 3Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 4Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 5Health News:Capsulated Systems, Inc. Develops Long Term Local Anesthetic 2
(Date:11/24/2009)...d.,Nov.24/PRNewswire-FirstCall/--ZimmerHoldings,In...ipatinginthe21stAnnualPiperJaffrayHealthCareConfer...asternTime. ,, Alivewebcastofthepresentationcan...tp://investor.zimmer.com .Thewebcastwillbearchived...mpany ,, Foundedin1927andheadquarteredinWarsaw...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--Orexigen®Therap...nyfocusedonthetreatmentofobesity,todayannouncedtha...pany,sBoardofDirectorsgrantedaninducementstockopti...ssen,M.D.,itsnewlyappointedHeadoftheGlobalContrave...tivestockoptiontotheextentpermittedbylawandhasanex...
(Date:11/24/2009)...Calif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc...ndevelopingandcommercializingnovelpainmanagementth...oitsBoardofDirectors,effectiveNovember19,2009.Mr.O...maceuticalindustryandhasbeeninstrumentalinthelaunc...rentlyservesasSeniorVicePresident,BioOncologyBusin...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Cardiac Science Announces Third Quarter Results 6112 1Cardiac Science Announces Third Quarter Results 6112 2Cardiac Science Announces Third Quarter Results 6112 3Cardiac Science Announces Third Quarter Results 6112 4Cardiac Science Announces Third Quarter Results 6112 5Cardiac Science Announces Third Quarter Results 6112 6Cardiac Science Announces Third Quarter Results 6112 7Cardiac Science Announces Third Quarter Results 6112 8Cardiac Science Announces Third Quarter Results 6112 9Cardiac Science Announces Third Quarter Results 6112 10Cardiac Science Announces Third Quarter Results 6112 11Cardiac Science Announces Third Quarter Results 6112 12Cardiac Science Announces Third Quarter Results 6112 13Cardiac Science Announces Third Quarter Results 6112 14Cardiac Science Announces Third Quarter Results 6112 15Cardiac Science Announces Third Quarter Results 6112 16Cardiac Science Announces Third Quarter Results 6112 17Cardiac Science Announces Third Quarter Results 6112 18Cardiac Science Announces Third Quarter Results 6112 19Cardiac Science Announces Third Quarter Results 6112 20Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 1Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 2Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 3Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 4Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 5Pharmasset to Present at Lazard Capital Markets Healthcare Conference 6106 1Pharmasset to Present at Lazard Capital Markets Healthcare Conference 6106 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 6106 3
...stant Skin Infections, SAN DIEGO, Sept. 22 Trius... of Phase 2 testing of the oral form of its,second...1. The multicenter,trial will test the efficacy, s... 300 and 400 milligrams of TR-701 in complicated s... to seven days of treatment., The study follows t...
... the Injectable Filler Market, PALO ALTO, Calif.,...launch of its Novielle Voice family of injectable ...n Academy of Otolaryngology -- Head,and Neck Surge...., The U.S. Food and Drug Administration (FDA) cl...s earlier this year for restoration of voice loss....
Other Medicine Technology:Trius Doses First Patient in Antibacterial Phase 2 Trial 2Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss 2
Laboratory Workstation; Vibration-Free Platform
TXG Series Stool 1G65
Adjustable Chrome-Plated Stool
...he ideal modular cleanroom for biological safety l...uire cleanliness (to Class 10/ISO 3) and easy ster...ltra-smooth surfaces that are easy to wipe down an...ning. Unique double-wall panel design creates stro...
Medicine Products: